| P50 | author | Roisin F. Kelly | Q42861892 |
| | Lionel Opie | Q61046058 |
| P2093 | author name string | Paul Thomas | |
| | Lionel H. Opie | |
| | Sarin Somers | |
| | Damian Hacking | |
| | Sandrine Lecour | |
| | Lydia Lacerda | |
| | Kim T. Lamont | |
| P2860 | cites work | American Journal of Physiology | Q2160146 |
| | Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury | Q24323877 |
| | Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection | Q28235893 |
| | Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning | Q28771386 |
| | Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 |
| | Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 |
| | Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury | Q33195698 |
| | Preconditioning protects by inhibiting the mitochondrial permeability transition | Q33201290 |
| | An essential role of the JAK-STAT pathway in ischemic preconditioning | Q33929635 |
| | Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations | Q34247485 |
| | New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway | Q34298555 |
| | The red wine hypothesis: from concepts to protective signalling molecules | Q34636347 |
| | Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? | Q34974091 |
| | Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion | Q36099739 |
| | Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning | Q80440977 |
| | Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice | Q81514899 |
| | Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection | Q82471465 |
| | No risk, no ... cardioprotection? A critical perspective | Q84480416 |
| | The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. | Q36122804 |
| | TNFα protects cardiac mitochondria independently of its cell surface receptors | Q36148170 |
| | Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore | Q36148247 |
| | Structure and function of fatty acid amide hydrolase | Q36161171 |
| | Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). | Q36533477 |
| | Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. | Q36836773 |
| | HDL and its sphingosine-1-phosphate content in cardioprotection | Q36842504 |
| | The myocardial JAK/STAT pathway: from protection to failure | Q37266843 |
| | Function of mitochondrial Stat3 in cellular respiration | Q37378567 |
| | TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 |
| | Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity. | Q39806718 |
| | Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine | Q40182562 |
| | The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta | Q40308442 |
| | Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling | Q40772249 |
| | Nano-liquid chromatography analysis of dansylated biogenic amines in wines | Q42164747 |
| | Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. | Q42844430 |
| | Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway | Q43295255 |
| | Role of STAT3 in ischemic preconditioning | Q43799529 |
| | Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection | Q44022447 |
| | Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? | Q44088292 |
| | Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene | Q44088296 |
| | Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder | Q44742906 |
| | Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity | Q44903331 |
| | Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways | Q45196279 |
| | Free radicals trigger TNF alpha-induced cardioprotection | Q45203259 |
| | The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction. | Q46001116 |
| | TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning | Q46224947 |
| | Ischemic postconditioning in pigs: no causal role for RISK activation. | Q46225223 |
| | Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury | Q46503010 |
| | Mitochondrial permeability transition pore as a target for cardioprotection in the human heart | Q46551313 |
| | Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate | Q46639803 |
| | TNFalpha-induced cytoprotection requires the production of free radicals within mitochondria in C2C12 myotubes | Q46737977 |
| | The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues | Q46772397 |
| | Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). | Q46847925 |
| | Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium | Q47275705 |
| | The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). | Q48094438 |
| | Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. | Q51476537 |
| | Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? | Q51752588 |
| | Changes of yolk biogenic amine concentrations during storage of shell hen eggs | Q58854766 |
| | Occurrence and evolution of amino acids during grape must cooking | Q59198719 |
| | Cardioprotection: nitric oxide, protein kinases, and mitochondria | Q79780264 |
| | High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor | Q80284338 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 763-770 | |
| P577 | publication date | 2010-10-12 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Ethanolamine is a novel STAT-3 dependent cardioprotective agent | |
| P478 | volume | 105 | |